Rapport Therapeutics (RAPP) · RAP-219
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: the fourth quarter of 2026
RAP-219 Phase 2 trial in bipolar mania topline results now expected in the fourth quarter of 2026
EX-99.1 · filed · SEC filing
After
Stated timing: October 2026
topline results are expected in October 2026.
SEC original · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/RAPP-rap-219-2026-08-05-2, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/RAPP-rap-219-2026-08-05-2
Rapport Therapeutics (RAPP) pipeline and stated timing · Calendar · Companies A–Z